AT309696B - Verfahren zur Herstellung neuer D-Arabinofuranosylpurinderivate - Google Patents

Verfahren zur Herstellung neuer D-Arabinofuranosylpurinderivate

Info

Publication number
AT309696B
AT309696B AT1028370A AT1028370A AT309696B AT 309696 B AT309696 B AT 309696B AT 1028370 A AT1028370 A AT 1028370A AT 1028370 A AT1028370 A AT 1028370A AT 309696 B AT309696 B AT 309696B
Authority
AT
Austria
Prior art keywords
arabinofuranosylpurine
derivatives
preparation
new
arabinofuranosylpurine derivatives
Prior art date
Application number
AT1028370A
Other languages
German (de)
English (en)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of AT309696B publication Critical patent/AT309696B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT1028370A 1969-11-17 1970-11-16 Verfahren zur Herstellung neuer D-Arabinofuranosylpurinderivate AT309696B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87744369A 1969-11-17 1969-11-17

Publications (1)

Publication Number Publication Date
AT309696B true AT309696B (de) 1973-08-27

Family

ID=25369972

Family Applications (1)

Application Number Title Priority Date Filing Date
AT1028370A AT309696B (de) 1969-11-17 1970-11-16 Verfahren zur Herstellung neuer D-Arabinofuranosylpurinderivate

Country Status (26)

Country Link
US (1) US3666856A (es)
JP (1) JPS5429520B1 (es)
AT (1) AT309696B (es)
BE (1) BE759011A (es)
BR (1) BR6915136D0 (es)
CA (1) CA967564A (es)
CH (2) CH555833A (es)
CS (1) CS181701B2 (es)
DE (1) DE2056327C2 (es)
DK (1) DK128117B (es)
ES (2) ES385590A1 (es)
FI (1) FI54315C (es)
FR (1) FR2073364B1 (es)
GB (2) GB1338905A (es)
HU (1) HU163812B (es)
IE (1) IE34737B1 (es)
IL (1) IL35658A (es)
LU (1) LU62071A1 (es)
MC (1) MC869A1 (es)
NL (1) NL171589C (es)
NO (1) NO128156B (es)
PL (1) PL81167B1 (es)
SE (1) SE385374B (es)
YU (2) YU35033B (es)
ZA (1) ZA707722B (es)
ZM (1) ZM12970A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081534A (en) * 1973-09-11 1978-03-28 Burroughs Wellcome Co. Amino purine nucleosides as autoimmune suppressant agents
GB1562899A (en) * 1975-06-17 1980-03-19 Wellcome Found Pharmaceutical compositions containing substituted 9-( -d-arabnofuranosyl)purine-5'-phosphate and salts thereof
US4210745A (en) * 1978-01-04 1980-07-01 The United States Of America As Represented By The Department Of Health, Education And Welfare Procedure for the preparation of 9-β-D-arabinofuranosyl-2-fluoroadenine
DE3319282A1 (de) * 1983-05-27 1984-11-29 Gödecke AG, 1000 Berlin Verwendung von adenosin bei der behandlung von herpes
GB8712745D0 (en) * 1987-05-30 1987-07-01 Wellcome Found Antiviral compounds
KR0138996B1 (ko) * 1988-03-16 1998-04-30 레이몬드 에이치. 칸 치환된 아데닌 유도체 및 이를 함유하는 약제학적 조성물
IE882585L (en) * 1988-08-25 1990-02-25 Prendergast Patrick T Viral treatment system
US5292725A (en) * 1988-08-25 1994-03-08 Prendergast Patrick T Administering particular compounds against various parasites, mycoplasmas, other indications and other infections
US5681941A (en) * 1990-01-11 1997-10-28 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
US5308837A (en) * 1990-08-22 1994-05-03 Merrell Dow Pharmaceuticals Inc. 5'-amine substituted adenosine analogs as immunosuppressants
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
US6232463B1 (en) 1997-10-09 2001-05-15 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
US6303617B1 (en) 1998-05-04 2001-10-16 Neotherapeutics, Inc. Serotonin-like 9-substituted hypoxanthine and methods of use
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) * 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
ES2385931T3 (es) 2000-07-07 2012-08-03 Spectrum Pharmaceuticals, Inc. MÉTODOS PARA EL TRATAMIENTO DE NEUROPATíA PERIFÉRICA INDUCIDA POR UNA ENFERMEDAD Y AFECCIONES RELACIONADAS.
US6759427B2 (en) 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
CN105237602B (zh) * 2015-06-25 2018-05-18 新乡学院 一种2-氨基阿糖腺苷的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3208997A (en) * 1962-11-15 1965-09-28 Sankyo Co Process for preparing purine and pyrimidine nucleosides
US3407191A (en) * 1966-08-29 1968-10-22 Lilly Co Eli Adamantoate esters of nucleosides
JPH1097965A (ja) * 1996-09-20 1998-04-14 Sony Corp 生産管理方法

Also Published As

Publication number Publication date
IE34737B1 (en) 1975-08-06
YU280670A (en) 1979-12-31
FI54315B (fi) 1978-07-31
YU35033B (en) 1980-06-30
NO128156B (es) 1973-10-08
NL7016766A (es) 1971-05-19
CA967564A (en) 1975-05-13
IL35658A0 (en) 1971-01-28
JPS5429520B1 (es) 1979-09-25
US3666856A (en) 1972-05-30
ZA707722B (en) 1972-06-28
YU35034B (en) 1980-06-30
ZM12970A1 (en) 1972-07-21
IL35658A (en) 1974-10-22
LU62071A1 (es) 1971-08-12
BE759011A (fr) 1971-05-17
CS181701B2 (en) 1978-03-31
NL171589B (nl) 1982-11-16
BR6915136D0 (pt) 1973-04-19
GB1338906A (en) 1973-11-28
SE385374B (sv) 1976-06-28
FR2073364B1 (es) 1974-03-22
HU163812B (es) 1973-10-27
FI54315C (fi) 1978-11-10
IE34737L (en) 1971-05-17
FR2073364A1 (es) 1971-10-01
ES413787A1 (es) 1976-01-16
GB1338905A (en) 1973-11-28
NL171589C (nl) 1983-04-18
DE2056327C2 (de) 1984-10-11
DE2056327A1 (de) 1971-06-03
MC869A1 (fr) 1971-09-28
DK128117B (da) 1974-03-04
CH555833A (de) 1974-11-15
ES385590A1 (es) 1973-10-01
PL81167B1 (es) 1975-08-30
YU201978A (en) 1979-12-31
CH555344A (de) 1974-10-31

Similar Documents

Publication Publication Date Title
CH535788A (de) Verfahren zur Herstellung neuer Benzodiazepinderivate
AT309696B (de) Verfahren zur Herstellung neuer D-Arabinofuranosylpurinderivate
CH541565A (de) Verfahren zur Herstellung neuer substituierter N-Allyl-2-arylamino-imidazoline-(2)
AT301752B (de) Verfahren zur Herstellung neuer Pleuromutilin-Derivate
CH529764A (de) Verfahren zur Herstellung neuer Pyrazolinderivate
AT306256B (de) Verfahren zur Herstellung neuer Benzomorphanderivate
AT298478B (de) Verfahren zur Herstellung neuer 2-Aminoindanderivate
AT301753B (de) Verfahren zur Herstellung neuer Pleuromutilin-Derivate
AT310361B (de) Verfahren zur Herstellung neuer Evomonosid-Derivate
AT301522B (de) Verfahren zur Herstellung neuer substituierter 2-Phenyl-2-hydroxy- oder acyloxy-1,1-dihalogenäthane
AT289776B (de) Verfahren zur Herstellung neuer 1-Carbamoyl-3-aroylpyrrolidine
CH530988A (de) Verfahren zur Herstellung neuer Diallylaminoalkanoylamide
CH542210A (de) Verfahren zur Herstellung neuer Dibenzazepinderivate
AT299916B (de) Verfahren zur Herstellung neuer bis-Aminobenzoate
CH516591A (de) Verfahren zur Herstellung neuer Thiazolopyrrolopyrimidine
AT297234B (de) Verfahren zur Herstellung neuer N(6)-Alkyl-adenosinderivate
CH498120A (de) Verfahren zur Herstellung neuer Indenopyridinderivate
AT301036B (de) Verfahren zur Herstellung neuer Neriifolin-Derivate
AT296296B (de) Verfahren zur Herstellung neuer Triazol-Derivate
CH513119A (de) Verfahren zur Herstellung neuer Halogencolchicinderivate
AT305253B (de) Verfahren zur Herstellung neuer Diphenoxyacetamide
AT319914B (de) Verfahren zur Herstellung neuer Triazapentadiene
CH539065A (de) Verfahren zur Herstellung neuer Triazolopyrimidinderivate
CH533633A (de) Verfahren zur Herstellung neuer Phenanthrotriazolylderivate
AT299176B (de) Verfahren zur Herstellung neuer Hexahydrophenanthrenderivate

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee